XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.25.2

STOCK OPTIONS AND WARRANTS (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
SCHEDULE OF STOCK OPTIONS | The following table summarizes all stock options as of June 30, 2025 (shares in thousands): SCHEDULE OF STOCK OPTIONS
|  | 2025 |
|  | Shares |  |  | Price (1) |  |  | Term (2) |
Outstanding, at December 31, 2024 |  |  | 1,238 |  |  | $ | 8.80 |  |  |  | 8.5 |
Granted |  |  | - |  |  |  | - |  |  |  |  |
Forfeited |  |  | (1 | ) |  |  | - |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |
Outstanding, at June 30 |  |  | 1,237 | (3) |  | $ | 8.80 |  |  |  | 8.0 |
Exercisable, at June 30 |  |  | 174 | (4) |  | $ | 39.85 |  |  |  | 2.6 |
(1) | Represents the weighted average exercise price.
(2) | Represents the weighted average remaining contractual term until the stock options expire.
(3) | As of June 30, 2025, the aggregate intrinsic value of stock options outstanding was $0.
(4) | As of June 30, 2025, the aggregate intrinsic value of exercisable stock options was $0.
SCHEDULE OF WARRANT OUTSTANDING | The following table sets forth activity with respect to the Company’s warrants to purchase Common Stock for the six months ended June 30, 2025 (shares in thousands): SCHEDULE OF WARRANT OUTSTANDING
|  | 2025 |
|  | Shares |  |  | Price (1) |  |  | Term (2) |
Outstanding, at December 31, 2024 |  |  | 9,658 |  |  | $ | 3.22 |  |  |  | 3.9 |
Grants of warrants: |  |  |  |  |  |  |  |  |  |  |  |
Private placement |  |  | 3,055 |  |  |  |  |  |  |  |  |
Exercised |  |  | - |  |  |  |  |  |  |  |  |
Forfeited |  |  | - |  |  |  |  |  |  |  |  |
Outstanding, at June 30 |  |  | 12,713 | (3) |  | $ | 2.86 |  |  |  | 3.6 |
Exercisable, at June 30 |  |  | 12,660 | (4) |  | $ | 2.40 |  |  |  | 3.5 |
(1) | Represents the weighted average exercise price.
(2) | Represents the weighted average remaining contractual term until the warrants expire.
(3) | As of June 30, 2025, the aggregate intrinsic value of warrants outstanding was $0 million.
(4) | As of June 30, 2025, the aggregate intrinsic value of warrants exercisable was $0 million.
Warrant [Member] |
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS USED IN THE FAIR VALUE | For the six months ended June 30, 2025, the valuation assumptions for warrants issued were estimated on the measurement date using the BSM option-pricing model with the following weighted-average assumptions: SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS USED IN THE FAIR VALUE
|  | 2025 |
Measurement date closing price of Common Stock (1) |  | $ | 2.14 |
Contractual term (years) (2) |  |  | 4.0 |
Risk-free interest rate |  |  | 4.0 | %
Volatility |  |  | 148 | %
Dividend yield |  |  | 0 | %
| (1) | Weighted average grant price.
| (2) | The valuation of warrants is based on the expected term.

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |